Evidence map›Paper›PMID 19729956›Full record

ArticleJournal of vascular research2010

Nitric oxide suppresses cerebral vasomotion by sGC-independent effects on ryanodine receptors and voltage-gated calcium channels.

Kathryn H Yuill, Alister J McNeish, Yasuo Kansui, Christopher J Garland, Kim A Dora

Open access · bronzeAbstract read
In one paragraph

Article in Journal of vascular research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Renal autoregulation in health and disease.Physiological reviews · 2015
    Review
  10. Review
  11. Systems biology of HBOC-induced vasoconstriction.Current drug discovery technologies · 2012
    Review
  12. Effects of somatothermal far-infrared ray on primary dysmenorrhea: a pilot study.Evidence-based complementary and alternative medicine : eCAM · 2012
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kathryn H Yuill *Department of Pharmacy and Pharmacology, University of Bath, Bath.
Alister J McNeish *Department of Pharmacy and Pharmacology, University of Bath, Bath.
Yasuo KansuiDepartment of Pharmacy and Pharmacology, University of Bath, Bath.
Christopher J GarlandDepartment of Pharmacology, University of Oxford, Oxford, UK.
Kim A DoraDepartment of Pharmacology, University of Oxford, Oxford, UK.
University of Bath · GBUniversity of Oxford · GB

Funding

British Heart Foundation FS/08/033/25111British Heart Foundation PG/04/069Wellcome Trust 07543/04Wellcome Trust 079677Wellcome Trust 089815
6 · The paper itself

Abstract

BACKGROUND/

aimsIn cerebral arteries, nitric oxide (NO) release plays a key role in suppressing vasomotion. Our aim was to establish the pathways affected by NO in rat middle cerebral arteries.

methodsIn isolated segments of artery, isometric tension and simultaneous measurements of either smooth muscle membrane potential or intracellular [Ca(2+)] ([Ca(2+)](SMC)) changes were recorded.

resultsIn the absence of L-NAME, asynchronous propagating Ca(2+) waves were recorded that were sensitive to block with ryanodine, but not nifedipine. L-NAME stimulated pronounced vasomotion and synchronous Ca(2+) oscillations with close temporal coupling between membrane potential, tone and [Ca(2+)](SMC). If nifedipine was applied together with L-NAME, [Ca(2+)](SMC) decreased and synchronous Ca(2+) oscillations were lost, but asynchronous propagating Ca(2+) waves persisted. Vasomotion was similarly evoked by either iberiotoxin, or by ryanodine, and to a lesser extent by ODQ. Exogenous application of NONOate stimulated endothelium-independent hyperpolarization and relaxation of either L-NAME-induced or spontaneous arterial tone. NO-evoked hyperpolarization involved activation of BK(Ca) channels via ryanodine receptors (RYRs), with little involvement of sGC. Further, in whole cell mode, NO inhibited current through L-type voltage-gated Ca(2+) channels (VGCC), which was independent of both voltage and sGC.

conclusionNO exerts sGC-independent actions at RYRs and at VGCC, both of which normally suppress cerebral artery myogenic tone.

Indexed as

Calcium SignalingVasoconstrictionVasodilationAnimalsCalciumCalcium Channel BlockersCalcium Channels, L-TypeDose-Response Relationship, DrugEndothelium, VascularEnzyme InhibitorsGuanylate CyclaseIn Vitro TechniquesLarge-Conductance Calcium-Activated Potassium ChannelsMaleMembrane PotentialsMiddle Cerebral ArteryCalciumCalcium Channel BlockersCalcium Channels, L-TypeEnzyme InhibitorsGuanylate CyclaseLarge-Conductance Calcium-Activated Potassium ChannelsNitric OxideNitric Oxide DonorsNitric Oxide SynthasePotassium Channel BlockersReceptors, Cytoplasmic and NuclearRyanodine Receptor Calcium Release ChannelSoluble Guanylyl Cyclase

Identifiers

PMID19729956
PMCPMC4826747
OpenAlexW2061551807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.